MPM BioImpact LLC

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

MPM BioImpact LLC sits at the top of its group. 7 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.

Filings

23 filings to the SEC since October 2021: 23 other. The latest 20:

1. Aug 14, 202613F-HR EDGAR
2. Aug 13, 2026N-PX EDGAR
3. May 15, 202613F-HR EDGAR
4. Feb 17, 202613F-HR EDGAR
5. Nov 14, 202513F-HR EDGAR
6. Aug 14, 202513F-HR EDGAR
7. Aug 12, 2025N-PX EDGAR
8. May 15, 202513F-HR EDGAR
9. Feb 14, 202513F-HR EDGAR
10. Nov 13, 202413F-HR EDGAR
11. Aug 21, 2024N-PX EDGAR
12. Aug 14, 202413F-HR EDGAR
13. May 15, 202413F-HR EDGAR
14. Feb 13, 202413F-HR EDGAR
15. Nov 14, 202313F-HR EDGAR
16. Aug 14, 202313F-HR EDGAR
17. May 12, 202313F-HR EDGAR
18. Feb 14, 202313F-HR EDGAR
19. Nov 14, 202213F-HR EDGAR
20. Aug 11, 202213F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

MPM BioImpact LLC has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).

• Climb Bio, Inc.SCHEDULE 13G/A Feb 17, 2026 to Aug 14, 2026²
• Context Therapeutics Inc.SCHEDULE 13G/A Jan 8, 2025 to Aug 14, 2026³
• DBV TechnologiesSCHEDULE 13G/A Feb 17, 2026 to Aug 14, 2026⁴
• Forte Biosciences, Inc.SCHEDULE 13G May 15, 2026⁵
• Compass Therapeutics, Inc.SCHEDULE 13G/A Feb 14, 2025 to Aug 12, 2025⁶
• Reunion NeuroscienceSC 13D/A Jun 12, 2023 to Aug 1, 2023⁷